Long-term responses to first-line antiretroviral therapy in HIV and hepatitis B co-infection in Ghana.
Identifieur interne : 000465 ( Main/Exploration ); précédent : 000464; suivant : 000466Long-term responses to first-line antiretroviral therapy in HIV and hepatitis B co-infection in Ghana.
Auteurs : Fred Stephen Sarfo [Ghana] ; Adetayo Kasim [Royaume-Uni] ; Richard Phillips [Ghana] ; Anna Maria Geretti [Royaume-Uni] ; David R. Chadwick [Royaume-Uni]Source :
- The Journal of infection [ 1532-2742 ] ; 2014.
Descripteurs français
- KwdFr :
- Adulte, Adulte d'âge moyen, Agents antiVIH (effets indésirables), Agents antiVIH (usage thérapeutique), Co-infection, Facteurs temps, Femelle, Foie (), Ghana, Humains, Hépatite B (), Hépatite B (immunologie), Infections à VIH (), Infections à VIH (immunologie), Infections à VIH (traitement médicamenteux), Mâle, Numération des lymphocytes CD4, Thérapie antirétrovirale hautement active (effets indésirables).
- MESH :
- effets indésirables : Agents antiVIH, Thérapie antirétrovirale hautement active.
- immunologie : Hépatite B, Infections à VIH.
- traitement médicamenteux : Infections à VIH.
- usage thérapeutique : Agents antiVIH.
- Adulte, Adulte d'âge moyen, Co-infection, Facteurs temps, Femelle, Foie, Ghana, Humains, Hépatite B, Infections à VIH, Mâle, Numération des lymphocytes CD4.
- Wicri :
- geographic : Ghana.
English descriptors
- KwdEn :
- Adult, Anti-HIV Agents (adverse effects), Anti-HIV Agents (therapeutic use), Antiretroviral Therapy, Highly Active (adverse effects), CD4 Lymphocyte Count, Coinfection, Female, Ghana, HIV Infections (complications), HIV Infections (drug therapy), HIV Infections (immunology), Hepatitis B (complications), Hepatitis B (immunology), Humans, Liver (drug effects), Male, Middle Aged, Time Factors.
- MESH :
- chemical , adverse effects : Anti-HIV Agents.
- chemical , therapeutic use : Anti-HIV Agents.
- geographic : Ghana.
- adverse effects : Antiretroviral Therapy, Highly Active.
- complications : HIV Infections, Hepatitis B.
- drug effects : Liver.
- drug therapy : HIV Infections.
- immunology : HIV Infections, Hepatitis B.
- Adult, CD4 Lymphocyte Count, Coinfection, Female, Humans, Male, Middle Aged, Time Factors.
Abstract
To observe the long term response to first-line antiretroviral therapy (ART) in HIV and hepatitis B virus (HBV) co-infected patients in Ghana and explore predictors of poor clinical outcomes.
DOI: 10.1016/j.jinf.2014.06.012
PubMed: 24975175
Affiliations:
Links toward previous steps (curation, corpus...)
- to stream PubMed, to step Corpus: 000091
- to stream PubMed, to step Curation: 000091
- to stream PubMed, to step Checkpoint: 000091
- to stream Ncbi, to step Merge: 000669
- to stream Ncbi, to step Curation: 000669
- to stream Ncbi, to step Checkpoint: 000669
- to stream Main, to step Merge: 000465
- to stream Main, to step Curation: 000465
Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Long-term responses to first-line antiretroviral therapy in HIV and hepatitis B co-infection in Ghana.</title><author><name sortKey="Sarfo, Fred Stephen" sort="Sarfo, Fred Stephen" uniqKey="Sarfo F" first="Fred Stephen" last="Sarfo">Fred Stephen Sarfo</name><affiliation wicri:level="1"><nlm:affiliation>Komfo Anokye Teaching Hospital, Kumasi, Ghana; Kwame Nkrumah University of Science and Technology, Kumasi, Ghana.</nlm:affiliation><country xml:lang="fr">Ghana</country><wicri:regionArea>Komfo Anokye Teaching Hospital, Kumasi, Ghana; Kwame Nkrumah University of Science and Technology, Kumasi</wicri:regionArea><wicri:noRegion>Kumasi</wicri:noRegion></affiliation></author><author><name sortKey="Kasim, Adetayo" sort="Kasim, Adetayo" uniqKey="Kasim A" first="Adetayo" last="Kasim">Adetayo Kasim</name><affiliation wicri:level="1"><nlm:affiliation>Wolfson Research Institute for Health and Wellbeing, Durham University, Stockton-on-Tees TS17 6BH, UK.</nlm:affiliation><country xml:lang="fr">Royaume-Uni</country><wicri:regionArea>Wolfson Research Institute for Health and Wellbeing, Durham University, Stockton-on-Tees TS17 6BH</wicri:regionArea><wicri:noRegion>Stockton-on-Tees TS17 6BH</wicri:noRegion></affiliation></author><author><name sortKey="Phillips, Richard" sort="Phillips, Richard" uniqKey="Phillips R" first="Richard" last="Phillips">Richard Phillips</name><affiliation wicri:level="1"><nlm:affiliation>Komfo Anokye Teaching Hospital, Kumasi, Ghana; Kwame Nkrumah University of Science and Technology, Kumasi, Ghana.</nlm:affiliation><country xml:lang="fr">Ghana</country><wicri:regionArea>Komfo Anokye Teaching Hospital, Kumasi, Ghana; Kwame Nkrumah University of Science and Technology, Kumasi</wicri:regionArea><wicri:noRegion>Kumasi</wicri:noRegion></affiliation></author><author><name sortKey="Geretti, Anna Maria" sort="Geretti, Anna Maria" uniqKey="Geretti A" first="Anna Maria" last="Geretti">Anna Maria Geretti</name><affiliation wicri:level="1"><nlm:affiliation>Institute of Global Health, University of Liverpool, L69 7BE, UK.</nlm:affiliation><country xml:lang="fr">Royaume-Uni</country><wicri:regionArea>Institute of Global Health, University of Liverpool, L69 7BE</wicri:regionArea><wicri:noRegion>L69 7BE</wicri:noRegion></affiliation></author><author><name sortKey="Chadwick, David R" sort="Chadwick, David R" uniqKey="Chadwick D" first="David R" last="Chadwick">David R. Chadwick</name><affiliation wicri:level="1"><nlm:affiliation>The James Cook University Hospital, Middlesbrough, TS4 3BW, UK. Electronic address: davidr.chadwick@stees.nhs.uk.</nlm:affiliation><country xml:lang="fr">Royaume-Uni</country><wicri:regionArea>The James Cook University Hospital, Middlesbrough, TS4 3BW</wicri:regionArea><wicri:noRegion>TS4 3BW</wicri:noRegion></affiliation></author></titleStmt><publicationStmt><idno type="wicri:source">PubMed</idno><date when="2014">2014</date><idno type="RBID">pubmed:24975175</idno><idno type="pmid">24975175</idno><idno type="doi">10.1016/j.jinf.2014.06.012</idno><idno type="wicri:Area/PubMed/Corpus">000091</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">000091</idno><idno type="wicri:Area/PubMed/Curation">000091</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">000091</idno><idno type="wicri:Area/PubMed/Checkpoint">000091</idno><idno type="wicri:explorRef" wicri:stream="Checkpoint" wicri:step="PubMed">000091</idno><idno type="wicri:Area/Ncbi/Merge">000669</idno><idno type="wicri:Area/Ncbi/Curation">000669</idno><idno type="wicri:Area/Ncbi/Checkpoint">000669</idno><idno type="wicri:Area/Main/Merge">000465</idno><idno type="wicri:Area/Main/Curation">000465</idno><idno type="wicri:Area/Main/Exploration">000465</idno></publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en">Long-term responses to first-line antiretroviral therapy in HIV and hepatitis B co-infection in Ghana.</title><author><name sortKey="Sarfo, Fred Stephen" sort="Sarfo, Fred Stephen" uniqKey="Sarfo F" first="Fred Stephen" last="Sarfo">Fred Stephen Sarfo</name><affiliation wicri:level="1"><nlm:affiliation>Komfo Anokye Teaching Hospital, Kumasi, Ghana; Kwame Nkrumah University of Science and Technology, Kumasi, Ghana.</nlm:affiliation><country xml:lang="fr">Ghana</country><wicri:regionArea>Komfo Anokye Teaching Hospital, Kumasi, Ghana; Kwame Nkrumah University of Science and Technology, Kumasi</wicri:regionArea><wicri:noRegion>Kumasi</wicri:noRegion></affiliation></author><author><name sortKey="Kasim, Adetayo" sort="Kasim, Adetayo" uniqKey="Kasim A" first="Adetayo" last="Kasim">Adetayo Kasim</name><affiliation wicri:level="1"><nlm:affiliation>Wolfson Research Institute for Health and Wellbeing, Durham University, Stockton-on-Tees TS17 6BH, UK.</nlm:affiliation><country xml:lang="fr">Royaume-Uni</country><wicri:regionArea>Wolfson Research Institute for Health and Wellbeing, Durham University, Stockton-on-Tees TS17 6BH</wicri:regionArea><wicri:noRegion>Stockton-on-Tees TS17 6BH</wicri:noRegion></affiliation></author><author><name sortKey="Phillips, Richard" sort="Phillips, Richard" uniqKey="Phillips R" first="Richard" last="Phillips">Richard Phillips</name><affiliation wicri:level="1"><nlm:affiliation>Komfo Anokye Teaching Hospital, Kumasi, Ghana; Kwame Nkrumah University of Science and Technology, Kumasi, Ghana.</nlm:affiliation><country xml:lang="fr">Ghana</country><wicri:regionArea>Komfo Anokye Teaching Hospital, Kumasi, Ghana; Kwame Nkrumah University of Science and Technology, Kumasi</wicri:regionArea><wicri:noRegion>Kumasi</wicri:noRegion></affiliation></author><author><name sortKey="Geretti, Anna Maria" sort="Geretti, Anna Maria" uniqKey="Geretti A" first="Anna Maria" last="Geretti">Anna Maria Geretti</name><affiliation wicri:level="1"><nlm:affiliation>Institute of Global Health, University of Liverpool, L69 7BE, UK.</nlm:affiliation><country xml:lang="fr">Royaume-Uni</country><wicri:regionArea>Institute of Global Health, University of Liverpool, L69 7BE</wicri:regionArea><wicri:noRegion>L69 7BE</wicri:noRegion></affiliation></author><author><name sortKey="Chadwick, David R" sort="Chadwick, David R" uniqKey="Chadwick D" first="David R" last="Chadwick">David R. Chadwick</name><affiliation wicri:level="1"><nlm:affiliation>The James Cook University Hospital, Middlesbrough, TS4 3BW, UK. Electronic address: davidr.chadwick@stees.nhs.uk.</nlm:affiliation><country xml:lang="fr">Royaume-Uni</country><wicri:regionArea>The James Cook University Hospital, Middlesbrough, TS4 3BW</wicri:regionArea><wicri:noRegion>TS4 3BW</wicri:noRegion></affiliation></author></analytic><series><title level="j">The Journal of infection</title><idno type="eISSN">1532-2742</idno><imprint><date when="2014" type="published">2014</date></imprint></series></biblStruct></sourceDesc></fileDesc><profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Adult</term><term>Anti-HIV Agents (adverse effects)</term><term>Anti-HIV Agents (therapeutic use)</term><term>Antiretroviral Therapy, Highly Active (adverse effects)</term><term>CD4 Lymphocyte Count</term><term>Coinfection</term><term>Female</term><term>Ghana</term><term>HIV Infections (complications)</term><term>HIV Infections (drug therapy)</term><term>HIV Infections (immunology)</term><term>Hepatitis B (complications)</term><term>Hepatitis B (immunology)</term><term>Humans</term><term>Liver (drug effects)</term><term>Male</term><term>Middle Aged</term><term>Time Factors</term></keywords><keywords scheme="KwdFr" xml:lang="fr"><term>Adulte</term><term>Adulte d'âge moyen</term><term>Agents antiVIH (effets indésirables)</term><term>Agents antiVIH (usage thérapeutique)</term><term>Co-infection</term><term>Facteurs temps</term><term>Femelle</term><term>Foie ()</term><term>Ghana</term><term>Humains</term><term>Hépatite B ()</term><term>Hépatite B (immunologie)</term><term>Infections à VIH ()</term><term>Infections à VIH (immunologie)</term><term>Infections à VIH (traitement médicamenteux)</term><term>Mâle</term><term>Numération des lymphocytes CD4</term><term>Thérapie antirétrovirale hautement active (effets indésirables)</term></keywords><keywords scheme="MESH" type="chemical" qualifier="adverse effects" xml:lang="en"><term>Anti-HIV Agents</term></keywords><keywords scheme="MESH" type="chemical" qualifier="therapeutic use" xml:lang="en"><term>Anti-HIV Agents</term></keywords><keywords scheme="MESH" type="geographic" xml:lang="en"><term>Ghana</term></keywords><keywords scheme="MESH" qualifier="adverse effects" xml:lang="en"><term>Antiretroviral Therapy, Highly Active</term></keywords><keywords scheme="MESH" qualifier="complications" xml:lang="en"><term>HIV Infections</term><term>Hepatitis B</term></keywords><keywords scheme="MESH" qualifier="drug effects" xml:lang="en"><term>Liver</term></keywords><keywords scheme="MESH" qualifier="drug therapy" xml:lang="en"><term>HIV Infections</term></keywords><keywords scheme="MESH" qualifier="effets indésirables" xml:lang="fr"><term>Agents antiVIH</term><term>Thérapie antirétrovirale hautement active</term></keywords><keywords scheme="MESH" qualifier="immunologie" xml:lang="fr"><term>Hépatite B</term><term>Infections à VIH</term></keywords><keywords scheme="MESH" qualifier="immunology" xml:lang="en"><term>HIV Infections</term><term>Hepatitis B</term></keywords><keywords scheme="MESH" qualifier="traitement médicamenteux" xml:lang="fr"><term>Infections à VIH</term></keywords><keywords scheme="MESH" qualifier="usage thérapeutique" xml:lang="fr"><term>Agents antiVIH</term></keywords><keywords scheme="MESH" xml:lang="en"><term>Adult</term><term>CD4 Lymphocyte Count</term><term>Coinfection</term><term>Female</term><term>Humans</term><term>Male</term><term>Middle Aged</term><term>Time Factors</term></keywords><keywords scheme="MESH" xml:lang="fr"><term>Adulte</term><term>Adulte d'âge moyen</term><term>Co-infection</term><term>Facteurs temps</term><term>Femelle</term><term>Foie</term><term>Ghana</term><term>Humains</term><term>Hépatite B</term><term>Infections à VIH</term><term>Mâle</term><term>Numération des lymphocytes CD4</term></keywords><keywords scheme="Wicri" type="geographic" xml:lang="fr"><term>Ghana</term></keywords></textClass></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">To observe the long term response to first-line antiretroviral therapy (ART) in HIV and hepatitis B virus (HBV) co-infected patients in Ghana and explore predictors of poor clinical outcomes.</div></front></TEI><affiliations><list><country><li>Ghana</li><li>Royaume-Uni</li></country></list><tree><country name="Ghana"><noRegion><name sortKey="Sarfo, Fred Stephen" sort="Sarfo, Fred Stephen" uniqKey="Sarfo F" first="Fred Stephen" last="Sarfo">Fred Stephen Sarfo</name></noRegion><name sortKey="Phillips, Richard" sort="Phillips, Richard" uniqKey="Phillips R" first="Richard" last="Phillips">Richard Phillips</name></country><country name="Royaume-Uni"><noRegion><name sortKey="Kasim, Adetayo" sort="Kasim, Adetayo" uniqKey="Kasim A" first="Adetayo" last="Kasim">Adetayo Kasim</name></noRegion><name sortKey="Chadwick, David R" sort="Chadwick, David R" uniqKey="Chadwick D" first="David R" last="Chadwick">David R. Chadwick</name><name sortKey="Geretti, Anna Maria" sort="Geretti, Anna Maria" uniqKey="Geretti A" first="Anna Maria" last="Geretti">Anna Maria Geretti</name></country></tree></affiliations></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/SidaGhanaV1/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000465 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 000465 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Wicri/Sante
|area= SidaGhanaV1
|flux= Main
|étape= Exploration
|type= RBID
|clé= pubmed:24975175
|texte= Long-term responses to first-line antiretroviral therapy in HIV and hepatitis B co-infection in Ghana.
}}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/RBID.i -Sk "pubmed:24975175" \
| HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd \
| NlmPubMed2Wicri -a SidaGhanaV1
| This area was generated with Dilib version V0.6.31. |  |